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Inflammatory cell infiltrate containing lymphocytes
and macrophages is often observed in periodontal
lesions. It is hypothesized that T-lymphocytes are pre-
dominant in stable lesions, whereas B-lymphocytes
and plasma cells are increased in progressive lesions
[1–6]. This suggests that Th1 cytokine expression T-cells
are the main regulators of inflammation in the early/
stable lesions. Production of interferon-gamma (IFN-γ)
can increase the phagocytosis of polymorphonuclear
neutrophils and macrophages, therefore inhibiting
the progression of infection. The predominance of 
B-lymphocytes and plasma cells in advanced progres-
sive lesions indicate the role of Th2 cells in the destruc-
tion of periodontal tissue. If the immune regulation is
inadequate, reduced level of interleukin-12 (IL-12)
often leads to low expression of Th1 and uncontrolled
infection. Stimulation of plasma cells can lead to the
production of IL-4 and promote the Th2 response, acti-
vation of B-cells, and antibody production. Antibody
can be protective by helping the elimination of infec-
tious agents; however, antibody can also be destructive
and lead to the progression of disease. Also, the con-
tinuous activation of B-cells promotes the production
of IL-1 that results in the destruction of supporting
osseous and connective tissues of the teeth.
Many studies have tried to elucidate the profile of
Th1/Th2 cell expression in periodontal disease by
various materials and methods. Some investigators
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Cytokines are pivotal to the immune response of chronic periodontitis. The present study investi-
gated the changes of gingival crevicular fluid (GCF) interleukin-4 (IL-4) and interferon-gamma
(IFN-γ) in patients with chronic periodontitis before and after initial nonsurgical periodontal
therapy (NSPT). GCF was collected from 17 patients by means of Periopaper® at baseline and 
1 month after NSPT. IL-4 and IFN-γ were measured by enzyme-linked immunoabsorbent assay.
NSPT resulted in decreased total amount of IFN-γ, increased concentration of IL-4, and increased
ratio of IL-4 to IFN-γ levels. We suggest that a low ratio of IL-4 to IFN-γ levels might be involved
in the destruction (diseased sites) of periodontal tissue, whereas an increased ratio of IL-4 to 
IFN-γ levels could be related to the improvement of clinical periodontal health.
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suggest the downregulation of Th1 cytokine in gingi-
val crevicular fluid (GCF) [7], gingival mononuclear
cells [8], and peripheral blood monocytes [9,10] from
periodontitis patients. Others reported increased Th2
response in GCF [11], gingival mononuclear cells [12],
peripheral blood monocytes [13,14], and gingival 
tissue [15–17] of periodontitis patients. These results
support the relationship of Th1 cells with stable peri-
odontal lesions, whereas the Th2 response is associated
with disease progression. However, many reports sug-
gest the predominance of Th1 response and, therefore,
a decreased Th2 response in periodontal diseased tis-
sues [18–20]. Studies [21,22] reporting that localized
low IL-4 in periodontal diseased tissue is related to dis-
ease activity and progression led to the hypothesis by
Shapira et al [21] that the localized absence of IL-4 can
trigger periodontal disease activity. Giannopoulou 
et al reported an inverse relationship between GCF
IL-4 level and periodontal status [23]. IL-4 was higher
in the periodontal healthy group, but very minute in
the periodontal diseased group [23]. This is in agree-
ment with Kabashima et al, i.e. lack of IL-4 in GCF
from severe inflammatory sites [22]. Similar results
were also reported in the mononuclear cells isolated
from inflamed gingival tissues [23,24]. All these find-
ings suggest that localized absence of IL-4 in gingival
tissue might lead to the development of periodontitis
from gingivitis [21].
IL-4 and IFN-γ together may regulate the immuno-
inflammatory response [25]. Ukai et al investigated the
IFN-γ- and IL-4-bearing cells in human periodontitis
gingival tissue and reported that the ratios of IL-4- to
IFN-γ-bearing cells in the severe inflammation or deep
pocket depth (PD) groups were significantly lower
than those in the moderate inflammation or shallow
PD groups [26]. The authors suggested that a low ratio
of IL-4- to IFN-γ-bearing cells might be involved in
the destruction of periodontal tissue. Salvi et al reported
that advanced adult periodontitis patients showed
higher GCF IFN-γ than IL-4, suggesting that longitu-
dinal follow-up in the levels and ratio of IFN-γ to IL-4
in GCF might be a useful indicator of periodontal 
tissue destruction [19].
IFN-γ and IL-4 represent Th1 and Th2 cytokines
produced by lymphocytes. Both cytokines play a role
in the regulation of the immunoinflammatory response
[27]. The aim of this study was to determine the influ-
ence of nonsurgical periodontal treatment (NSPT) on
the levels of IFN-γ and IL-4 in GCF.
MATERIALS AND METHODS
Subject selection
Seventeen Chinese adult non-smoking patients (11
males, 6 females; age range, 32–64 years) were selected
from those being treated at the Department of Peri-
odontics, Dental Clinic, Kaohsiung Medical University,
Taiwan. The enrolment criteria were at least 20 teeth,
no antibiotic or non-steroidal anti-inflammatory drug
usage within 3 months, and no periodontal treatment
within 6 months. Additional exclusion criteria were
pregnancy or lactation, diabetes, HIV infection, bleed-
ing disorders, and any condition necessitating anti-
biotic premedication for dental appointment. The
institutional review board of Kaohsiung Medical
University approved the study. Informed consent was
obtained from all subjects.
GCF collection and clinical parameters
Each clinical evaluation was preceded by collection
of GCF from the mesiobuccal surfaces of maxillary
teeth (right second premolar to left second premolar,
excluding teeth with dental restoration) to avoid saliva
contamination. Briefly, teeth were air dried and iso-
lated with cotton rolls, supragingival plaque was gen-
tly removed, and GCF samples were collected with
Periopaper® (GCF collection strips, Proflow, Amityville,
NY, USA) for 30 seconds. Paper strips were measured
for fluid volume with a calibrated Periotron 8000
(Oraflow Inc., Plainview, NY, USA), and then removed
to separate microcentrifuge tubes containing 100 μL
physiologic saline 0.1% Tween 20. The tubes were
stored at −70°C until eluted. Following elution, each
GCF sample was analyzed separately.
Clinical measurement was performed immediately
after the GCF collection. Probing PD is the distance in
millimeters from the most coronal margin of free gin-
gival to the most apical penetration of the probe.
Probing attachment level (PAL) is the distance in mil-
limeters from the cementoenamel junction to the most
apical penetration of the probe. PD and PAL were
measured using a Williams periodontal probe (Hu-
Friedy™, Chicago, IL, USA) at six sites per tooth. The
gingival index (GI) and the plaque index (PLI) were
recorded dichotomously during GCF collection [28,29].
The sample sites were categorized into groups of PD
< 6 mm and ≥ 6 mm, PAL < 6 mm and ≥ 6 mm. Only
sites of PD and PAL ≥ 4 mm (4–10 mm) at baseline
were subjected to data analysis.
Assays of IL-4 and IFN-g
After grinding paper strips with microcentrifuge 
pestles, each sample was eluted in 500 μL phosphate
buffered saline containing 0.1% Tween 20 by centri-
fugation (1,500 g, 10 min, 4°C). Following elution,
GCF samples were analyzed for IL-4 and IFN-γ using
commercially available enzyme-linked immunoab-
sorbent assays (ELISA, R&D System Inc., MN, USA).
Analyses were performed according to the manufac-
turer’s recommended protocol. Concentration of each
GCF substance was calculated with a standard curve
obtained with each standard recombinant GCF sub-
stance. Total amount of each GCF substance was ob-
tained by multiplying concentration and GCF volume.
Cytokine concentration of site lower than the detect-
able range was estimated statistically as one-half of
the lowest value of the detectable site at the time 
of ELISA.
After the baseline clinical periodontal data were
collected, patients were arranged to receive NSPT con-
sisting of scaling and root planning with ultrasonic
cavitron and curette ranging from five to seven ses-
sions. Clinical periodontal parameters were reassessed
1 month after the completion of NSPT.
Statistical analysis
All data analyses were done using JMP and SAS 
(SAS Institute, Cary, NC, USA). Data are presented as
mean ± standard deviation. Significance of mean dif-
ferences between sites were tested by paired t test,
assigning significance for two-tailed p < 0.05. Relation-
ships among mean clinical parameters and GCF cyto-
kines were tested by analysis of variance followed by
a post hoc comparison using Tukey’s pair-wise t test.
The associations between the levels of various GCF
substances and clinical parameters were calculated
using Pearson’s correlation and expressed by Pearson’s
correlation coefficient.
RESULTS
Baseline levels of IL-4 and IFN-g in GCF
Non-significant differences for IL-4 and IFN-γ (Table 1)
were observed for different PD or PAL site-groups.
Influence of NSPT on levels of IL-4 and
IFN-g in GCF
Significant improvements (p < 0.0001) in clinical peri-
odontal parameters (GCF volume, PLI, GI, PD, PAL)
were achieved by NSPT (Tables 2 and 3); however,
only total amount of IFN-γ was significantly decreased
(p < 0.05), and concentration of IL-4 was significantly
increased (p < 0.001).
Influence of NSPT on ratios of IL-4 levels
and IFN-g levels in GCF
The ratios of the total amounts and concentrations of
IL-4 to IFN-γ after NSPT were significantly higher
(p < 0.0001) than at baseline (Table 4).
IL-4 and IFN-g in chronic periodontitis
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Table 1. Baseline levels of interleukin-4 (IL-4) and interferon-gamma (IFN-γ) in gingival crevicular fluid*
IL-4 (pg) IFN-γ (pg) IL-4 (pg/μL) IFN-γ (pg/μL)
(n = 47) (n = 47) (n = 47) (n = 47)
PD
< 6 0.155 ± 0.188 0.150 ± 0.240 0.153 ± 0.171 0.161 ± 0.242
(n = 22) (n = 22) (n = 22) (n = 22)
≥ 6 0.163 ± 0.167 0.204 ± 0.277 0.172 ± 0.227 0.211 ± 0.260
(n = 25) (n = 25) (n = 25) (n = 25)
p 0.8754 0.4803 0.7500 0.5046
PAL
< 6 0.160 ± 0.197 0.164 ± 0.252 0.153 ± 0.155 0.168 ± 0.241
(n = 17) (n = 17) (n = 17) (n = 17)
≥ 6 0.159 ± 0.165 0.188 ± 0.266 0.168 ± 0.225 0.198 ± 0.258
(n = 30) (n = 30) (n = 30) (n = 30)
p 0.9790 0.7707 0.8142 0.6980
*Data are presented as mean ± standard deviation. IL-4 (pg) = total amount of IL-4; IFN-γ (pg) = total amount of IFN-γ; IL-4 (pg/μL) =
concentration of IL-4; IFN-γ (pg/μL) = concentration of IFN-γ; n = number of sample sites; PD = probing pocket depth (mm); PAL =
probing attachment level (mm).
DISCUSSION
After NSPT, the total amount of IL-4 was not changed,
but the concentration of IL-4 was significantly in-
creased. This is different from the results of Kabashima
et al who reported no detectable IL-4 in GCF from
severe inflammation sites, but IL-4 could be detected
after periodontal treatment [22]. However, Kabashima
et al and we are in agreement that IL-4 might play a
role in regulating the degree of local inflammation in
periodontal disease [22].
Giannopoulou et al reported an inverse relationship
between GCF IL-4 and periodontal status, i.e. the
healthy group showed higher IL-4 than the diseased
group, which had only minute IL-4 [23]. This is in
agreement with our results. Ginnopoulou et al also
indicated that IL-4 is negatively related with PD [23].
After NSPT, the total amount of IFN-γ was signifi-
cantly decreased. NSPT resulted in the improvement
of periodontal health; therefore, we suggest that the
decrease in IFN-γ was related to the manifestation of
periodontal lesions. This is in agreement with the
suggestion of Ebersole and Taubman [18]. Salvi et al,
in their study of inflammation mediators of the termi-
nal dentition in adult and early-onset periodontitis,
reported that the concentrations of GCF IFN-γ is higher
than IL-4 in severe advanced adult periodontitis [19].
They concluded that Th1 is significantly higher than
Th2 in severe advanced periodontitis.
In the present study, we compared the ratios of
GCF IL-4 to IFN-γ in the baseline and post-NSPT sites
and found that IL-4 to IFN-γ ratios were increased
after NSPT. We suggest an association of the increased
IL-4 to IFN-γ ratio with the improvement of peri-
odontal status. Since IL-4 and IFN-γ represent Th1
and Th2 cytokines, the expression of IL-4 and IFN-γ
has some relationship with the subpopulations of 
T-cells; in other words, Th1 might be predominant 
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Table 2. Influence of nonsurgical periodontal therapy (NSPT) on periodontal parameters*
PLI GI PD PAL
(n = 47) (n = 47) (n = 47) (n = 47)
Baseline 1.489 ± 0.804 1.915 ± 0.620 6.255 ± 1.621 6.660 ± 1.773
Post-NSPT 0.766 ± 0.865 1.511 ± 0.505 4.191 ± 1.597 5.574 ± 1.862
Difference –0.723 ± 0.772 –0.404 ± 0.712 –2.064 ± 1.436 –1.085 ± 1.472
p < 0.0001 0.0003 < 0.0001 < 0.0001
*Data are presented as mean ± standard deviation. PLI = plaque index; GI = gingival index; PD = probing pocket depth (mm); PAL =
probing attachment level (mm); n = number of sample sites.
Table 3. Influence of nonsurgical periodontal therapy (NSPT) on the levels of interleukin-4 (IL-4) and interferon-
gamma (IFN-γ) in gingival crevicular fluid (GCF)*
GCF (μL) IL-4 (pg) IFN-γ (pg) IL-4 (pg/μL) IFN-γ (pg/μL)
(n = 47) (n = 47) (n = 47) (n = 47) (n = 47)
Baseline 1.039 ± 0.349 0.159 ± 0.175 0.179 ± 0.259 0.163 ± 0.201 0.188 ± 0.250
Post-NSPT 0.342 ± 0.232 0.127 ± 0.121 0.120 ± 0.180 0.463 ± 0.667 0.377 ± 0.798
Difference –0.697 ± 0.384 –0.032 ± 0.195 –0.069 ± 0.203 0.301 ± 0.619 0.189 ± 0.649
p† < 0.0001 0.2606 0.0235 0.0017 0.0514
*Data are presented as mean ± standard deviation; †Wilcoxon signed rank test. IL-4 (pg) = total amount of IL-4; IFN-γ (pg) = total
amount of IFN-γ; IL-4 (pg/μL) = concentration of IL-4; IFN-γ (pg/μL) = concentration of IFN-γ; n = number of sample sites.
Table 4. Influence of nonsurgical periodontal treat-
ment (NSPT) on the ratios of interleukin-4 (IL-4) levels to
interferon-gamma (IFN-γ) levels in gingival crevicular
fluid*
IL-4 (pg)/ IL-4 (pg/μL)/
IFN-γ (pg) IFN-γ (pg/μL)
(n = 47) (n = 47)
Baseline 4.8 ± 5.8 2.5 ± 2.7
Post-NSPT 12.4 ± 19.4 18.8 ± 29.9
Difference 7.7 ± 18.6 16.4 ± 29.6
p 0.0068 0.0004
*Data are presented as mean ± standard deviation. IL-4 (pg) =
total amount of IL-4; IFN-γ (pg) = total amount of IFN-γ; IL-4
(pg/μL) = concentration of IL-4; IFN-γ (pg/μL) = concentra-
tion of IFN-γ; n = number of sample sites.
in periodontal lesions, and Th2 might be more likely
to be related with the remission of periodontal inflam-
mation. Ukai et al discovered that ratios of IL-4- to
IFN-γ-bearing cells in the severe inflammation or deep
PD (≥5mm) groups were significantly lower than those
in the moderate or shallow PD groups [26]. These
investigators suggest that a low ratio of IL-4- to IFN-γ-
bearing cells might be involved in the destruction of
periodontal tissue and support our current findings.
In addition, our present study found that the change
in IL-4 to IFN-γ ratio is mainly due to the significant
decrease of IFN-γ by NSPT. Zong et al reported that
the level of blood serum IFN-γ and IL-4 in patients
with chronic periodontitis was significantly higher
than the control group; however, only IFN-γ (not IL-4)
concentration was reduced significantly in spite of the
improvement in sulcular bleeding index and probing
depth by initial periodontal therapy. This finding
seems to be in agreement with or supporting our
present results.
NSPT could significantly improve periodontal sta-
tus. After NSPT, the total amount of IFN-γ decreased
significantly, but IL-4 to IFN-γ ratios of both total
amount and concentration were increased.
In conclusion, we suggest that Th1 cytokine as
represented by IFN-γ might be predominant in chronic
periodontitis lesions; Th2 cytokine as represented by
IL-4 was associated with the remission or improve-
ment of periodontal inflammation. A longitudinal
observation may be helpful to more clearly define the
role of GCF IL-4 and IFN-γ in the process of periodon-
tal treatment.
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